Search

everythinglearnresearchcommunity

for

Search:↓

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Non-obese women with hair loss have higher heart disease risk.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Dihydrotestosterone might cause migraines, and finasteride could help reduce them.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Oral contraceptives can effectively treat acne by reducing oil production.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Resveratrol helps prevent finasteride-induced damage in male rats, improving reproductive function.

Finasteride may help reduce alcohol cravings and related brain activity.

The new gel for hair loss is safe, effective, and reduces side effects.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.